info icon

This is a non-core endpoint: only basic statistics are computed.

Transepidermal elimination disorders

L12_TRANSEPIDERMELIMINATION

skin disease: Any deviation from the normal structure or function of the skin or subcutaneous tissue that is manifested by a characteristic set of symptoms and signs.

Endpoint definition

FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 L87
Cause of death: ICD-10 L87

2 out of 7 registries used, show all original rules.

-

diagram downward connector

Check minimum number of events None

-

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

42

diagram downward connector
L12_TRANSEPIDERMELIMINATION

Control definitions

Control exclude L12_OTHERSKINSUBCUTIS

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 L80-L99
Name in latin Perturbationes eliminationis transepidermalis

Similar endpoints

List of similar endpoints to Transepidermal elimination disorders based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 42 27 15
Unadjusted prevalence (%) 0.01 0.01 0.01
Mean age at first event (years) 52.63 51.76 54.18

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: L12_TRANSEPIDERMELIMINATION – Transepidermal elimination disorders
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Transepidermal elimination disorders

Endpoint not on priority list, no data to show.